Viral mimic systems and other tech platforms could enable local testing of vaccine candidates and antiviral therapies. This is important in the context of low-resourced health settings, Africa's focus ...

CD Bioparticles launches comprehensive OMV-Based Bacterial Vaccines Development services for infectious disease and ...

What if vaccine development didn’t have to take a decade? This piece looks at how AI is helping scientists ask better questions, test smarter, and respond faster.

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. While the media's attention has focused on unproven links between ...

The global autogenous vaccines market is growing steadily, valued at around US$ 312.4 million in 2026 and projected to reach US$ 451.5 million by 2033, ...